Why Rumble (RUM) Stock Is Trading Up Today

Stock Story

What Happened?

Shares of video sharing platform Rumble (NASDAQGM:RUM) jumped 3.7% in the afternoon session after investor interest grew in its proposed business combination with Northern Data AG, which was intended to expand the company's AI and high-performance computing infrastructure. The company said the transaction would add one of the largest collections of GPUs in Europe and a data center business. Rumble expected this would help scale its cloud operations, accelerate international expansion, and advance its AI roadmap for creators, video, and advertising. The deal's acceptance and closing were expected in the second quarter of 2026.

After the initial pop the shares cooled down to $5.98, up 4.1% from previous close.

What Is The Market Telling Us

Rumble’s shares are extremely volatile and have had 43 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 1 day ago when the stock dropped 0.2% on the news that geopolitical tensions between the United States and the European Union escalated, sparking fears of a renewed trade war.

The broader markets adopted a "risk-off" mode, with investors seeking safe-haven assets amidst the uncertainty. The market's primary fear gauge, the VIX, jumped to a fresh eight-week high, signaling rising investor anxiety. The dispute, centered on Greenland, raised the possibility of a revived trade conflict, which could disrupt global supply chains and economic activity. Mega-cap technology stocks, many of which have significant international sales and operations, were particularly affected by the souring risk sentiment as a potential trade war threatens their global business models.

Rumble is down 6.2% since the beginning of the year, and at $5.98 per share, it is trading 56.1% below its 52-week high of $13.61 from January 2025.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Taboola, Rumble, Xerox, and ManpowerGroup Stocks Trade Down, What You Need To Know

Stock Story

Taboola.com Ltd. Warrant

0.00%

Xerox

-6.77%

What Happened?

A number of stocks fell in the afternoon session after geopolitical tensions between the United States and the European Union escalated, sparking fears of a renewed trade war.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

Advertising & Marketing Services company Taboola fell 2%. Is now the time to buy Taboola? Access our full analysis report here, it’s free.
Digital Media & Content Platforms company Rumble fell 0.2%. Is now the time to buy Rumble? Access our full analysis report here, it’s free.
Hardware & Infrastructure company Xerox fell 6.4%. Is now the time to buy Xerox? Access our full analysis report here, it’s free.
Professional Staffing & HR Solutions company ManpowerGroup fell 2.3%. Is now the time to buy ManpowerGroup? Access our full analysis report here, it’s free.

Zooming In On Xerox (XRX)

Xerox’s shares are extremely volatile and have had 40 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 6 months ago when the stock dropped 19.6% on the news that the company reported a significant loss for its second quarter and widely missed analyst profit forecasts.

The company posted an adjusted loss of $0.64 per share, a stark contrast to the $0.07 profit analysts had predicted. While revenue slightly surpassed expectations, this earnings failure alarmed investors. The company's financial health showed clear signs of strain as its free cash flow, a key measure of cash generation, plunged to a negative $30 million from a positive $115 million in the prior year. This decline stemmed from falling gross margins, which were squeezed by tariffs and increased product costs. Revenue from the core Print and Other segment also contracted, which highlighted soft demand for the company's equipment.

Xerox is up 2.6% since the beginning of the year, but at $2.53 per share, it is still trading 74.3% below its 52-week high of $9.84 from January 2025. Investors who bought $1,000 worth of Xerox’s shares 5 years ago would now be looking at an investment worth $119.95.

Risk Warnings and Disclaimers

Add to Favorites

Eli Lilly and Regencell among market cap stock movers on Wednesday

Investing.com

Advanced Micro Devices

-3.64%

Ambarella

-1.43%

Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Eli Lilly and Regencell Bioscience Holdings are rallying, while others like First Solar are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers (Market Cap:$200 billion USD and higher)

Eli Lilly And Co (LLY); Eli Lilly & Co. (LLY) Nears Deal for Ventyx Biosciences (VTYX) - WSJ: +3.59%
Google Inc (GOOGL): +3.18%
Palantir Technologies Inc (PLTR): +2.99%
AbbVie Inc (ABBV): +2.38%
Caterpillar (CAT); Caterpillar CEO Joe Creed to become chairman as Umpleby retires: -3.11%
United Health Group (UNH): -2.41%
Bank Of America (BAC); Wolfe Research downgrades Bank of America stock rating on valuation concerns: -2.47%
JP Morgan Chase (JPM); Wolfe Research downgrades JPMorgan stock rating on expected slower EPS growth: -2.26%
Lam Research Corp (LRCX): -2.26%
Applovin (APP): +3.27%

Large-Cap Stock Movers (Market Cap:$10-$200 billion USD)

Regencell Bioscience Holdings (RGC): +45.47%
Bloom Energy Corp (BE): +7.52%
Intel Corp (INTC); Mobileye to acquire humanoid robotics firm Mentee for $900 million: +6.69%
Invitation Homes Inc (INVH): -7.9%
Vistra Energy Corp (VST): -7.83%
Seagate Technology (STX): -6.95%
Amern Hms 4 (AMH): -5.25%
Western Digital (WDC): -8.9%
First Solar Inc (FSLR): -10.0%
New Providence Acquisition Corp N (ASTS); Scotiabank downgrades AST Spacemobile stock on valuation concerns: -11.54%

Mid-Cap Stock Movers (Market Cap:$2-$10 billion USD)

Crinetics Pharmaceuticals Inc (CRNX); Crinetics Pharmaceuticals prices public offering at $45.95 per share: +13.0%
Compass (COMP); Compass announces proposed $750 million convertible notes offering: +12.79%
CF Acquisition Corp VI (RUMBW): +9.07%
Arrowhead Research Corp (ARWR); Arrowhead Pharmaceuticals plans to offer $700 million in securities: -8.95%
Cleveland Cliffs (CLF); Cleveland-Cliffs stock rating downgraded by KeyBanc on valuation concerns: -9.53%
Qorvo Inc (QRVO): -8.74%
ViaSat (VSAT): -11.38%
Skyworks Solutions Inc (SWKS): -11.64%
Fermi America LLC (FRMI): -11.0%
Ambarella Inc (AMBA): -12.36%

Small-Cap Stock Movers (Market Cap:$300 million - $2 billion USD)

Monte Rosa Therapeutics (GLUE); Monte Rosa’s MRT-8102 shows promising results in reducing inflammation: +49.41%
NovaBay Pharmaceuticals Inc (NBY): +42.22%
Ventyx Biosciences (VTYX); Eli Lilly-Ventyx Deal Could Come Wednesday, Sources Say -- WSJ: +36.67%
Realogy Holdings (HOUS): +20.93%
AXT Inc (AXTI): +19.43%
Neumora Therapeutics (NMRA): +18.76%
GH Research (GHRS): +22.52%
Immuneering (IMRX): +22.17%
ASTX NYSE (ASTX): -3.33%
Summit Semiconductor (DVLT): -17.21%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

Add to Favorites

Eli Lilly and Intel lead market cap stock movers on Wednesday

Investing.com

NovaBay Pharmaceuticals

-17.58%

Alphabet-A

-2.36%

Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Eli Lilly and Intel are rallying, while others like Western Digital and Hecla Mining are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers (Market Cap:$200B and above)

Eli Lilly And Co (LLY); Eli Lilly & Co. (LLY) Nears Deal for Ventyx Biosciences (VTYX) - WSJ: +3.67%
Google Inc (GOOGL): +1.69%
JP Morgan Chase (JPM); Wolfe Research downgrades JPMorgan stock rating on expected slower EPS growth: -2.8%
Lam Research Corp (LRCX): -2.31%
Facebook Inc (META): -2.28%
Adv Micro Device (: -1.83%
Alibaba-exch (BABA); Freedom Capital Markets downgrades Alibaba stock rating amid rising costs: -2.19%

Large-Cap Stock Movers (Market Cap:$10B-$200B)

Intel Corp (INTC); Mobileye to acquire humanoid robotics firm Mentee for $900 million: +10.89%
Regencell Bioscience Holdings (RGC): +25.79%
First Solar Inc (FSLR): -9.27%
Hecla Mining Comp (HL): -9.5%
Western Digital (WDC): -8.41%
Seagate Technology (STX): -7.64%
New Providence Acquisition Corp N (ASTS); Scotiabank downgrades AST Spacemobile stock on valuation concerns: -5.54%
CoStar Group (CSGP); CoStar Group sets financial targets, announces $1.5 billion buyback: -4.48%

Mid-Cap Stock Movers (Market Cap:$2B-$10B)

Crinetics Pharmaceuticals Inc (CRNX); Crinetics Pharmaceuticals prices public offering at $45.95 per share: +15.66%
Navan Inc (NAVN): +7.53%
Pbf Energy Inc (PBF): +5.62%
Frontline Ltd Ordinary Shares (FRO): +6.9%
Compass (COMP); Compass announces proposed $750 million convertible notes offering: +6.14%
CF Acquisition Corp VI (RUMBW): +9.07%
Skyworks Solutions Inc (SWKS): -10.97%
Arrowhead Research Corp (ARWR); Arrowhead Pharmaceuticals plans to offer $700 million in securities: -6.89%
ViaSat (VSAT): -4.81%
Fermi America LLC (FRMI): -10.16%

Small-Cap Stock Movers (Market Cap:$300M-$2B)

Monte Rosa Therapeutics (GLUE); Monte Rosa to present interim results for NEK7-directed MGD: +54.28%
Ventyx Biosciences (VTYX); Eli Lilly-Ventyx Deal Could Come Wednesday, Sources Say -- WSJ: +37.31%
Neumora Therapeutics (NMRA): +31.87%
NovaBay Pharmaceuticals Inc (NBY): +19.28%
AXT Inc (AXTI): +18.84%
Erasca (ERAS); Piper Sandler initiates Erasca stock with Overweight rating, $5 price target: +16.25%
Immuneering (IMRX): +16.82%
Realogy Holdings (HOUS); Compass announces proposed $750 million convertible notes offering: +13.91%
MBX Biosciences (MBX); UBS initiates coverage on MBX Biosciences stock with Buy rating: +14.91%
ASTX NYSE (ASTX): -0.93%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

Add to Favorites

2 Reasons to Watch RUM and 1 to Stay Cautious

Stock Story

What a brutal six months it’s been for Rumble. The stock has dropped 27.2% and now trades at $6.54, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Following the pullback, is now the time to buy RUM? Find out in our full research report, it’s free for active Edge members.

Why Does RUM Stock Spark Debate?

Founded in 2013 as a champion for content creator rights and free expression, Rumble is a video sharing platform that positions itself as a free speech alternative to mainstream platforms, offering creators more favorable revenue-sharing opportunities.

Two Positive Attributes:

1. Skyrocketing Revenue Shows Strong Momentum

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Thankfully, Rumble’s 85.5% annualized revenue growth over the last four years was incredible. Its growth surpassed the average business services company and shows its offerings resonate with customers.

2. Projected Revenue Growth Is Remarkable

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite, though some deceleration is natural as businesses become larger.

Over the next 12 months, sell-side analysts expect Rumble’s revenue to rise by 202%, an improvement versus its 85.5% annualized growth for the past four years. This projection is eye-popping and suggests its newer products and services will spur better top-line performance.

One Reason to be Careful:

Free Cash Flow Margin Dropping

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Rumble’s margin dropped by 46.7 percentage points over the last five years. It may have ticked higher more recently, but shareholders are likely hoping for its margin to at least revert to its historical level. If the longer-term trend returns, it could signal it’s in the middle of a big investment cycle. Rumble’s free cash flow margin for the trailing 12 months was negative 53.1%.

Rumble Trailing 12-Month Free Cash Flow Margin

Final Judgment

Rumble has huge potential even though it has some open questions. After the recent drawdown, the stock trades at 34.6× forward EV-to-EBITDA (or $6.54 per share). Is now a good time to initiate a position? See for yourself in our in-depth research report, it’s free for active Edge members.

Risk Warnings and Disclaimers

Add to Favorites

Coupang and Xpeng among market cap stock movers on Friday

Investing.com

Friday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Coupang (CPNG) and Xpeng (XPEV) are rallying, while stocks like dMY Technology Group III ( are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Large-Cap Stock Movers ($10-$200 billion USD)

Coupang (CPNG) +9.06%
Xpeng (XPEV) +7.1%
New Providence Acquisition Corp N (ASTS) -5.89%
Vector Acquisition (RKLB) -6.74%
Regencell Bioscience Holdings (RGC) -6.59%
dMY Technology Group III (IONQ) -6.3%
AltC Acquisition (OKLO) -4.58%
Yandex (NBIS) -3.71%
Iris Energy (IREN) -4.56%
Bitmine Immersion Tech (BMNR) -4.02%

Mid-Cap Stock Movers ($2-$10 billion USD)

Fly Leasing Ltd (FLY) -10.61%
CF Acquisition Corp VI (RUMBW) -13.62%
Pony Ai Inc (PONY) -8.1%
DPCM Capital (QBTS) -7.99%
Hut 8 Mining PK (HUT) -6.99%
China Telecom Corp Ltd (CHA) -6.35%
Nuscale Power (SMR) -6.22%
Lemonade Inc (LMND) -6.61%
Sustainable Opportunities Acqui (TMC) -7.61%
WeShop Holdings Ltd (WSHP) +10.11%

Small-Cap Stock Movers ($300 million - $2 billion USD)

Starfighters Space (FJET) +28.31%
Studio City International Holdings (MSC) +14.93%
Dingdong ADR (DDL) +14.52%
Thunder Bridge Capital Partners IV (CNCK) +10.79%
Flame Acquisition (SOC) -13.79%
IONX (IONX) -13.2%
Fast Acquisition Corp II (FBYD) -16.03%
Cryptyde (ORBS) -10.16%
Inflection Point Acquisition II (USAR) -6.98%
Lionheart III (SMX) -5.6%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

Add to Favorites

Micron Tech and Nike among market cap stock movers on Wednesday

Investing.com

Edgewise Therapeutics

-0.04%

UiPath

-2.68%

Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Micron Tech and Nike are rallying, while others like New Providence Acquisition Corp N are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers (Market Cap:$200B+ USD)

Micron Tech (MU) +3.77%
Costco Whsl Corp New (COST) +2.0%

Large-Cap Stock Movers (Market Cap:$10-$200B USD)

Nike (NKE) +4.64%
DPCM Capital (QBTS) -5.56%
New Providence Acquisition Corp N (ASTS) -8.89%
Amark Preci (GOLD) +3.11%

Mid-Cap Stock Movers (Market Cap:$2-$10B USD)

Edgewise Therapeutics (EWTX); Edgewise reports positive interim safety data for HCM drug EDG-7500 +25.5%
Retrophin I (TVTX) +13.91%
Uipath (PATH) +7.46%
Grupo Aeromexico (AERO) +6.07%
CF Acquisition Corp VI (RUMBW) +6.5%
Mudrick Capital A (HYMC) -8.03%

Small-Cap Stock Movers (Market Cap:$300M-$2B USD)

Omeros Corp (OMER); FDA approves Omeros’ Yartemlea for stem cell transplant complication +75.54%
Dynavax Tech (DVAX); Sanofi to acquire Dynavax for $2.2 billion in cash deal +38.19%
Thunder Bridge Capital Partners IV (CNCK) +19.53%
Agios Pharm (AGIO); FDA approves Agios’ AQVESME for thalassemia anemia treatment +18.63%
Phoenix Asia Holdings (PHOE) +14.81%
Polestar Automotive Holding Plc (PSNY) +13.55%
Kodiak Sciences Inc (KOD) +13.22%
ZKH ADR (ZKH) +12.07%
Aspirational Consumer Lifestyle (UP) +12.11%
Jyong Biotech (MENS) -11.44%